Abstract:Diabetic kidney disease (DKD) is the principal culprit behind chronic kidney disease (CKD), ultimately developing end-stage renal disease (ESRD) and necessitating costly dialysis or kidney transplantation. The limited therapeutic efficiency among individuals with DKD is a result of our finite understanding of its pathogenesis. DKD is the result of complex interactions between various factors. Oxidative stress is a fundamental factor that can establish a link between hyperglycemia and the vascular complications frequently encountered in diabetes, particularly DKD. It is crucial to recognize the essential and integral role of oxidative stress in the development of diabetic vascular complications, particularly DKD. Hyperglycemia is the primary culprit that can trigger an upsurge in the production of reactive oxygen species (ROS), ultimately sparking oxidative stress. The main endogenous sources of ROS include mitochondrial ROS production, NADPH oxidases (Nox), uncoupled endothelial nitric oxide synthase (eNOS), xanthine oxidase (XO), cytochrome P450 (CYP450), and lipoxygenase. Under persistent high glucose levels, immune cells, the complement system, advanced glycation end products (AGEs), protein kinase C (PKC), polyol pathway, and the hexosamine pathway are activated. Consequently, the oxidant–antioxidant balance within the body is disrupted, which triggers a series of reactions in various downstream pathways, including phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), transforming growth factor beta/p38-mitogen-activated protein kinase (TGF-β/p38-MAPK), nuclear factor kappa B (NF-κB), adenosine monophosphate-activated protein kinase (AMPK), and the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling. The disease might persist even if strict glucose control is achieved, which can be attributed to epigenetic modifications. The treatment of DKD remains an unresolved issue. Therefore, reducing ROS is an intriguing therapeutic target. The clinical trials have shown that bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 (Nrf2) activator, blood glucose-lowering drugs, such as sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists can effectively slow down the progression of DKD by reducing oxidative stress. Other antioxidants, including vitamins, lipoic acid, Nox inhibitors, epigenetic regulators, and complement inhibitors, present a promising therapeutic option for the treatment of DKD. In this review, we conduct a thorough assessment of both preclinical studies and current findings from clinical studies that focus on targeted interventions aimed at manipulating these pathways. We aim to provide a comprehensive overview of the current state of research in this area and identify key areas for future exploration.

Oxidative stress-mediated mesangial cell proliferation requires RAC-1/reactive oxygen species production and beta4 integrin expression

Oxidized High-Density Lipoprotein Enhances Inflammatory Activity in Rat Mesangial Cells

Oxidative stress in diabetic nephropathy: basic and clinical information

Oxidative stress-dependent Ras-ERK activation involves in aldosterone-induced mesangial cell proliferation

Glomerular mesangial cell and oxidative stress

The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.

Activation of FoxO1/ PGC-1α Prevents Mitochondrial Dysfunction and Ameliorates Mesangial Cell Injury in Diabetic Rats.

Aldosterone induces mesangial cell proliferation via PI3K-Akt-mTOR-p70S6K1 activation

Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-β signaling in mesangial cells

Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic Nephropathy

Peroxisome Proliferator-Activated Receptor-Agonist Inhibited Angiotensin Ⅱ Induced Monocyte Chemoattractant Protein-1 Expression in Human Mesangial Cells

Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease

Pioglitazone Inhibits the Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase and P38 Mitogen-Activated Protein Kinase in Rat Mesangial Cells

High Glucose Induces Renal Mesangial Cell Proliferation and Fibronectin Expression Through JNK/NF-κB/NADPH Oxidase/ros Pathway, Which is Inhibited by Resveratrol

The Attenuation of Moutan Cortex on Oxidative Stress for Renal Injury in AGEs-induced Mesangial Cell Dysfunction and Streptozotocin-Induced Diabetic Nephropathy Rats.

Enhanced Cellular Oxidant Stress by the Interaction of Advanced Glycation End Products with Their Receptors/binding Proteins

The Effect of FoxO1 on the Proliferation of Rat Mesangial Cells under High Glucose Conditions.

Suppression Of Xbp1s Mediates High Glucose-Induced Oxidative Stress And Extracellular Matrix Synthesis In Renal Mesangial Cell And Kidney Of Diabetic Rats

Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions

A Ppar Gamma Agonist Inhibits Aldosterone-Induced Mesangial Cell Proliferation by Blocking Ros-Dependent Egfr Intracellular Signaling